Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
This study has been completed.
Study NCT00003107 Information provided by Indiana University
First Received: November 1, 1999 Last Updated: September 15, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Gestational Trophoblastic Tumor
Kidney Cancer
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma, Renal Cell
Gestational Trophoblastic Neoplasms
Kidney Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Multiple Myeloma
Myeloproliferative Disorders
Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms, Plasma Cell
Ovarian Neoplasms
Preleukemia
Syndrome
Trophoblastic Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adnexal Diseases
Blood Protein Disorders
Bone Marrow Diseases
Breast Diseases
Carcinoma
Cardiovascular Diseases
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Kidney Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Ovarian Diseases
Paraproteinemias
Pathologic Processes
Precancerous Conditions
Pregnancy Complications
Pregnancy Complications, Neoplastic
Skin Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Vascular Diseases
Interventions listed in this trial
recombinant interleukin-12
Additional drug interventions recognized in this trial
Interleukin-12
More general drug interventions related to this trial
Adjuvants, Immunologic
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Indiana University School of Medicine
National Cancer Institute (NCI)
Back to top of Main Content
